Clinical trials for ivermectin

Numerous prophylaxis trials demonstrate that regular ivermectin use leads to large reductions in transmission. The current evidence on the use of ivermectin to treat COVID-19 patients is inconclusive

2024-03-19
    Olanzapine treatment for anorexia nervosa
  1. Secondary endpoint was the occurrence of adverse events
  2. 03, 95% CI 0
  3. Approval: 1996